Waneta C. Tuttle

Waneta C.
Tuttle is the founder of DNA Electronics, Inc. (founded in 2007), Exagen, Inc. (founded in 2002), PhDx Systems, Inc. (founded in 1994), and Tramway Ventures LLC (founded in 2017).
She holds the title of Director at DNA Electronics, Inc., Interim Chief Executive Officer at Exagen, Inc., Chairman at PhDx Systems, Inc., and Managing Partner at Tramway Ventures LLC.
Dr. Tuttle currently holds the position of Director at Agilvax, Inc., Tramway Technologies LLC, Armonica Technologies, Inc., BennuBio, Inc., WaveFront Dynamics, Inc., Circular Genomics, Inc., Vitazi Ai, Inc., and Tramway Life Sciences LLC.
She is also an Advisor at Tullis Health Investors, Inc. and a Member at The University of New Mexico.
Dr. Tuttle has previously worked as Chief Executive Officer at Indigo Medical, Inc., Director at MGI PHARMA, Inc., Director at Health Care Service Corp., Director at The National Center for Genome Resources, Member at The Charles Stark Draper Laboratory, Inc., and Chief Operating Officer & Vice President at Lovelace Medical Group.
Dr. Tuttle's education includes an undergraduate degree and an MBA from The University of New Mexico.